Home » Topics » Briefs » Other news to note

Other news to note
RSS

Jounce Therapeutics reviews its next-generation immunotherapy pipeline

Jan. 17, 2018

InflaRx presents company and pipeline overview

Jan. 16, 2018

Prolong Pharmaceuticals gives update on ongoing projects

Jan. 16, 2018

GeneDx enters research collaboration with the Radboud University

Jan. 15, 2018

AnaptysBio: treating severe inflammatory diseases

Jan. 15, 2018

Aviragen reiterates support for pending merger with Vaxart

Jan. 12, 2018

Ligand and Glenmark enter OmniAb license agreement

Jan. 12, 2018

HedgePath to receive new investment from Mayne Pharma

Jan. 12, 2018

CEO describes development activity at Alkermes

Jan. 12, 2018

Galapagos obtains rights to MALT1 inhibitors for inflammatory and/or oncological diseases

Jan. 11, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...